Pharmaceutical Technology5 小时
Risk adjusted net present value: What is the current valuation of Jasper Therapeutics’s ...
Briquilimab is a monoclonal antibody commercialized by Jasper Therapeutics, with a leading Phase II program in Severe Combined Immune Deficiency (SCID).